Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.

Journal: Cancer Cell

Published: 2018-09-10

DOI: 10.1016/j.ccell.2018.08.002

Affiliations: 32

Authors: 47

Go to article
Institutions FC
Bioinformatics and Computational Systems Biology of Cancer, France 0.11
Hopp Children's Tumor Center at NCT Heidelberg (KiTZ), Germany 0.09
German Consortium of Translational Cancer Research (DKTK), Germany 0.09
Protein Mass Spectrometry Laboratory, Curie Institute, France 0.09
Curie Institute, France 0.08
Department of Paediatric Oncology, Haematology and Immunology, HHU, Germany 0.07
Paris Descartes University (Paris 5), France 0.06
Institute of Neuropathology, HHU, Germany 0.05
Laboratoire de Neuropathologie, Hospital Sainte-Anne, France 0.04
French National Centre for Scientific Research (CNRS), France 0.04
National Institute for Health and Medical Research (INSERM), France 0.04
Normal and Pathological Development of Melanocytes, France 0.04
Division of Pediatric Neurooncology, DKFZ, Germany 0.03
DKTK Partner Site Essen/Düsseldorf, Germany 0.03
Hôpital Necker-Enfants Malades, France 0.02
Genetics and Biology of Cancers, France 0.02
Division of Haematology/Oncology, SickKids U of T, Canada 0.02
Department of Child and Adolescent Cancer, IGR, France 0.02
Clinical Cooperation Unit Neuropathology, DKFZ, Germany 0.01
Department of Neuropathology, Uni Heidelberg, Germany 0.01
Department of Pediatric Oncology, Hematology and Immunology, Uni Heidelberg, Germany 0.01
Centre de Recherche, Institut Curie, France 0.01
Arthur and Sonia Labatt Brain Tumour Research Centre, SickKids U of T, Canada 0
Developmental and Stem Cell Biology, SickKids U of T, Canada 0
Division of Neurosurgery, SickKids U of T, Canada 0
Department of Surgery, U of T, Canada 0
Department of Medical Biophysics, U of T, Canada 0

Return